Position in AMGN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$2,195,533
+$157,266 QoQ
Shares Held
6,063
+4.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.31%
of 13F equity value
Holder Rank
#1,233
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Providence Wealth Advisors, LLC holds $29,228,180 across 9 Drug Manufacturers - General names. AMGN ranks #4 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,369 | $14,835,750 | |
| 2 | ABBV |
AbbVie Inc.
|
12,831 | $3,228,792 | |
| 3 | JNJ |
Johnson & Johnson
|
10,046 | $2,551,382 | |
| 4 | AMGN |
Amgen Inc
This page
|
6,063 | $2,195,533 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
15,197 | $1,919,988 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
31,560 | $1,818,487 | |
| 7 | MRK |
Merck & Co., Inc.
|
11,036 | $1,418,126 | |
| 8 | PFE |
Pfizer Inc
|
44,086 | $1,061,590 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,195,533 | 6,063 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $2,038,267 | 5,793 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,880,068 | 5,744 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,611,079 | 5,709 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,606,574 | 5,754 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,755,272 | 5,634 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,452,025 | 5,571 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,778,921 | 5,521 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,690,666 | 5,411 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,504,337 | 5,291 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $612,330 | 2,126 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,318,805 | 4,907 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,071,690 | 4,827 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,243,078 | 5,142 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,339,989 | 5,102 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,121,815 | 4,977 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,257,617 | 5,169 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,148,645 | 4,750 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,047,010 | 4,654 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $987,546 | 4,644 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,128,318 | 4,629 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,152,736 | 4,633 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,013,487 | 4,408 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,062,897 | 4,182 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $807,584 | 3,424 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $665,765 | 3,284 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||